Growth Metrics

PACS (PACS) EBITDA Margin: 2022-2024

Historic EBITDA Margin for PACS (PACS) over the last 3 years, with FY2024 value amounting to 3.01%.

  • PACS's EBITDA Margin rose 41800.0% to 6.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.63%, marking a year-over-year increase of 22600.0%. This contributed to the annual value of 3.01% for FY2024, which is 36700.0% down from last year.
  • As of FY2024, PACS's EBITDA Margin stood at 3.01%, which was down 36700.0% from 6.68% recorded in FY2023.
  • In the past 5 years, PACS's EBITDA Margin ranged from a high of 9.47% in FY2022 and a low of 3.01% during FY2024
  • In the last 3 years, PACS's EBITDA Margin had a median value of 6.68% in 2023 and averaged 6.39%.
  • Per our database at Business Quant, PACS's EBITDA Margin crashed by -27900bps in 2023 and then crashed by -36700bps in 2024.
  • Annual analysis of 3 years shows PACS's EBITDA Margin stood at 9.47% in 2022, then dropped by -29bps to 6.68% in 2023, then tumbled by -55bps to 3.01% in 2024.
  • Its last three reported values are 3.01% in FY2024, 6.68% for FY2023, and 9.47% during FY2022.